Metabolomics: A biomarker to improve the assessment of central nervous system positive acute lymphoblastic leukaemia?
Br J Haematol
.
2022 Sep;198(6):939-940.
doi: 10.1111/bjh.18353.
Epub 2022 Jul 19.
Author
John Moppett
1
Affiliation
1
Bristol Royal Hospital for Children, Bristol, UK.
PMID:
35852474
DOI:
10.1111/bjh.18353
No abstract available
MeSH terms
Acute Disease
Biomarkers
Central Nervous System
Central Nervous System Neoplasms*
Humans
Metabolomics
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
Substances
Biomarkers